Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α-neutralizing antibody

Author： Mori Shunsuke   Imamura Fumiya   Kiyofuji Chikage   Sugimoto Mineharu  

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.16, Iss.4, 2006-08, pp. : 251-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

By Onishi Sachiko   Yoshio Taku   Nagashima Takao   Minota Seiji  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 528-530

Springer Publishing Company

Access to resources Recommend Favorite

Suboptimal Clinical Response to Anti-tumor Necrosis Factor alpha (TNFα) Antibody Therapy in a Patient with Severe Rheumatoid Arthritis and Lymphadenopathy: CASE REPORT

By Saeki Yukihiko   Ohshima Shiro   Mima Toru   Sasai Mitsuko   Nishioka Katsuhiro   Shimizu Masatoshi   Suemura Masaki   McCloskey Richard   Kishimoto Tadamitsu  

Scandinavian Journal of Rheumatology, Vol. 27, Iss. 4, 1998-08 ,pp. : 303-305

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Partial Remission of AutoImmune Thrombocytopenia in a Patient Treated with the Anti-Tumor Necrosis Factor-Alpha Antibody Infliximab for Refractory Fistulizing Crohn’s Disease

By  

Digestion, Vol. 78, Iss. 4, 2008-12 ,pp. : 195-200

Karger

Access to resources Recommend Favorite

Knee joint destruction driven by residual local symptoms after anti-tumor necrosis factor therapy in rheumatoid arthritis

By Imagama Takashi  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 823-828

Springer Publishing Company

Access to resources Recommend Favorite

Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment?

By Nagashima Takao   Minota Seiji  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 819-820

Springer Publishing Company

Access to resources Recommend Favorite